Closing Bell Overtime: Stocks Sink, Fed Up & Weight Watchers' Big Deal 3/7/23
Closing Bell
00:00
Weight Watchers' Strategic Expansion into Prescription Weight Loss Drug Business
The chapter explores Weight Watchers' shift towards the prescription weight loss drug business through the acquisition of telehealth company Sequence, analyzing the scientific foundation, behavior change focus, and integration of biological and genetic understandings of obesity in their approach. It discusses responses from the pharmaceutical industry, emphasizing the importance of combining medications with lifestyle changes for effective weight loss management and the need to counter misinformation with evidence-based treatments.
Play episode from 26:04
Transcript
